Psychopharmacology and Psychiatry Updates

Podcast autorstwa Psychopharmacology Institute

Kategorie:

242 Odcinki

  1. On Methylphenidate and Sleep: A Two-Year Study

    Opublikowany: 17.11.2024
  2. Nature's Pharmacy: Combining Natural Remedies in Psychiatry

    Opublikowany: 12.11.2024
  3. Breaking the Cycle: Memantine in Body-Focused Repetitive Behaviors

    Opublikowany: 7.11.2024
  4. The Potential of Ashwagandha in Psychiatry

    Opublikowany: 2.11.2024
  5. Treatment Dilemmas: ECT for Depressed Teens

    Opublikowany: 28.10.2024
  6. CBD in Psychiatry: Promise or Hype?

    Opublikowany: 23.10.2024
  7. Beyond Dopamine: Cannabidiol in Parkinson's Care

    Opublikowany: 18.10.2024
  8. Is NAC Promising in Bipolar and Depression Treatment?

    Opublikowany: 13.10.2024
  9. Microbes and the Mind: Probiotics and ADHD

    Opublikowany: 8.10.2024
  10. Lithium, Lamotrigine, and Labor: Managing Bipolar Disorder in Expectant Mothers

    Opublikowany: 3.10.2024
  11. Rethinking Haloperidol in Geriatric Delirium

    Opublikowany: 28.09.2024
  12. Antipsychotics in Pregnancy: A Balancing Act

    Opublikowany: 23.09.2024
  13. Risperidone in Youth Anorexia: A Promising Solution?

    Opublikowany: 18.09.2024
  14. Navigating Lithium: A Guide for Expectant Mothers with Bipolar Disorder

    Opublikowany: 13.09.2024
  15. DORA: A New Frontier in Insomnia Treatment

    Opublikowany: 8.09.2024
  16. Debunking Myths: Lithium Use in Pregnancy

    Opublikowany: 3.09.2024
  17. SSRIs and Kids: Escitalopram for Pediatric Anxiety

    Opublikowany: 29.08.2024
  18. Unraveling Treatment Resistance: A Psychodynamic Approach

    Opublikowany: 24.08.2024
  19. Psychedelics: A New Frontier in Psychiatry

    Opublikowany: 19.08.2024
  20. Beyond the Prescription Pad: Navigating Patient Ambivalence

    Opublikowany: 14.08.2024

1 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site